Stakeholder Engagement in Type 1 Diabetes Research, Quality Improvement, and Clinical Care.
Partnership approaches
Public and patient involvement
Quality improvement
Stakeholder engagement
Type 1 diabetes
Journal
Endocrinology and metabolism clinics of North America
ISSN: 1558-4410
Titre abrégé: Endocrinol Metab Clin North Am
Pays: United States
ID NLM: 8800104
Informations de publication
Date de publication:
Mar 2024
Mar 2024
Historique:
medline:
26
1
2024
pubmed:
26
1
2024
entrez:
25
1
2024
Statut:
ppublish
Résumé
The integration of stakeholder engagement (SE) in research, quality improvement (QI), and clinical care has gained significant traction. Type 1 diabetes is a chronic disease that requires complex daily management and care from a multidisciplinary team across the lifespan. Inclusion of key stakeholder voices, including patients, caregivers, health care providers and community advocates, in the research process and implementation of clinical care is critical to ensure representation of perspectives that match the values and goals of the patient population. This review describes the current framework for SE and its application to research, QI, and clinical care across the lifespan.
Identifiants
pubmed: 38272594
pii: S0889-8529(23)00078-6
doi: 10.1016/j.ecl.2023.09.007
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
165-182Informations de copyright
Copyright © 2023 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Authors’ disclosures R.M. Wolf receives research support from Novo Nordisk as the site PI of a clinical trial.